by Nakita | Jun 18, 2026 | Blog, Latest News
We are delighted to welcome Eleanor and Ann-Marie to the Lupus UK Staff Team! Eleanor has joined the Fundraising & Marketing Development team as our Fundraising & Stewardship Officer, and Ann-Marie has joined the Community Services team as our Community...
by Nakita | Jun 11, 2026 | Latest News, Research Opportunities
In this article, we use “lupus” instead of “SLE” (systemic lupus erythematosus). In England and Wales, doctors can use a medicine called obinutuzumab to treat kidney disease caused by lupus. You might know this as lupus nephritis. Research has shown that obinutuzumab...
by Nakita | May 22, 2026 | Latest News
People living with immune-mediated inflammatory diseases (IMIDs), including lupus, in Scotland face persistent challenges in accessing timely diagnosis, equitable care, and the support needed to manage lifelong, complex conditions. The Scottish Report, led by the...
by Nakita | May 21, 2026 | Research Opportunities
Why have you been asked? Obinutuzumab is a medicine that has just been approved for the treatment of kidney disease in people with lupus. Michael Robson’s research team are planning a study on the best way to use it. They would like to ask people with lupus for...
by Nakita | May 21, 2026 | Research Opportunities
From Partner to Caregiver: Identity Change and its Consequences in Autoimmune Disease This research explores how romantic partners of people with flare‑remitting autoimmune diseases, such as lupus, experience the shift from being a partner to becoming a caregiver....
